(Q37507989)

20 August 2017

1 reference

title

Treatment of narcolepsy. (English)

1 reference

20 August 2017

0 references

2

1 reference

20 August 2017

Giuseppe Didato

1

1 reference

20 August 2017

publication date

1 June 2009

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

20 August 2017

published in

1 reference

20 August 2017

volume

9

1 reference

20 August 2017

issue

6

1 reference

20 August 2017

page(s)

897-910

1 reference

Clinical and neurobiological aspects of narcolepsy

20 August 2017

cites work

1 reference

Narcolepsy with cataplexy

21 January 2018

1 reference

Therapeutic advances in narcolepsy

21 January 2018

1 reference

Prevalence of narcolepsy symptomatology and diagnosis in the European general population

21 January 2018

1 reference

Factors associated with a delay in the diagnosis of narcolepsy

21 January 2018

1 reference

Age at onset of narcolepsy in two large populations of patients in France and Quebec.

21 January 2018

1 reference

Familial patterns of narcolepsy

21 January 2018

1 reference

The neurobiology, diagnosis, and treatment of narcolepsy

21 January 2018

1 reference

Ultradian aspects of sleep in narcolepsy.

21 January 2018

1 reference

Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched controls

21 January 2018

1 reference

Dynamics of slow wave activity in narcoleptic patients under bed rest conditions.

21 January 2018

1 reference

Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management

21 January 2018

1 reference

Corticospinal excitability during laughter: implications for cataplexy and the comparison with REM sleep atonia

21 January 2018

1 reference

Pharmacotherapy for cataplexy

21 January 2018

1 reference

Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives

21 January 2018

1 reference

21 January 2018

1 reference

Night-time sleep and daytime sleepiness in narcolepsy

21 January 2018

1 reference

The association between narcolepsy and REM behavior disorder (RBD).

21 January 2018

1 reference

Increased body-mass index in patients with narcolepsy.

21 January 2018

1 reference

A putative link between childhood narcolepsy and obesity

21 January 2018

1 reference

Sleep disorders and depressive feelings: a global survey with the Beck depression scale

21 January 2018

1 reference

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

21 January 2018

1 reference

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

21 January 2018

1 reference

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

21 January 2018

1 reference

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

21 January 2018

1 reference

Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis

21 January 2018

1 reference

Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs

21 January 2018

1 reference

A putative flip-flop switch for control of REM sleep

21 January 2018

1 reference

Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system

21 January 2018

1 reference

EFNS guidelines on management of narcolepsy.

21 January 2018

1 reference

An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy

21 January 2018

1 reference

Pharmacotherapy for excessive daytime sleepiness.

21 January 2018

1 reference

Modafinil increases histamine release in the anterior hypothalamus of rats

21 January 2018

1 reference

Clinical pharmacokinetic profile of modafinil

21 January 2018

1 reference

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

21 January 2018

1 reference

Dosing Regimen Effects of Modafinil for Improving Daytime Wakefulness in Patients With Narcolepsy

21 January 2018

1 reference

A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy

21 January 2018

1 reference

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy

21 January 2018

1 reference

Modafinil in the treatment of excessive daytime sleepiness in children

21 January 2018

1 reference

Sodium oxybate: a review of its use in the management of narcolepsy

21 January 2018

1 reference

Selegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study

21 January 2018

1 reference

Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy.

21 January 2018

1 reference

Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy.

21 January 2018

1 reference

No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy

21 January 2018

1 reference

Armodafinil for excessive daytime sleepiness

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.09.29

1 reference

20 August 2017

1 reference